Bank of America
CLGN icon

Bank of America’s CollPlant Biotechnologies CLGN Stock Holding History

Bank of America’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$3.5K – 5935
2025
Q4 		$3.5K Hold
2,500
– – ﹤0.01% 6322
2025
Q3 		$6.72K Hold
2,500
– – ﹤0.01% 7270
2025
Q2 		$3.4K Hold
2,500
– – ﹤0.01% 7353
2025
Q1 		$6.45K Hold
2,500
– – ﹤0.01% 7188
2024
Q4 		$9K Sell
2,500
-325
-12% -$1.32K ﹤0.01% 7005
2024
Q3 		$14K Sell
2,825
-4,475
-61% -$21.9K ﹤0.01% 6824
2024
Q2 		$36.3K Hold
7,300
– – ﹤0.01% 6593
2024
Q1 		$39.1K Hold
7,300
– – ﹤0.01% 6591
2023
Q4 		$46.6K Hold
7,300
– – ﹤0.01% 6619
2023
Q3 		$40.7K Sell
7,300
-89
-1% -$589 ﹤0.01% 6555
2023
Q2 		$60.3K Hold
7,389
– – ﹤0.01% 6386
2023
Q1 		$51.9K Buy
7,389
+2,589
+54% +$25.4K ﹤0.01% 6494
2022
Q4 		$40.1K Hold
4,800
– – ﹤0.01% 6548
2022
Q3 		$33K Buy
+4,800
New +$38.9K ﹤0.01% 6829

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Bank of America's CLGN Position: Q1 2026 in Review

Bank of America sold out of CollPlant Biotechnologies (CLGN) in Q1 2026, closing a stake of 2,500 shares — an estimated $3.5K sold.

Bank of America first reported a position in CLGN in Q3 2022 and held it in 14 quarters. The position peaked at $60.3K in Q2 2023. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Bank of America reported no remaining CollPlant Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2,500 CollPlant Biotechnologies shares in Q1 2026, an estimated $3.5K.
  • Bank of America first reported a position in CollPlant Biotechnologies in Q3 2022 and held it in 14 quarters.
  • Bank of America's CollPlant Biotechnologies position peaked at $60.3K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.